Jump to main content
Jump to site search

Issue 19, 2017
Previous Article Next Article

Gadolinium-based nanoscale MRI contrast agents for tumor imaging

Author affiliations

Abstract

Gadolinium-based nanoscale magnetic resonance imaging (MRI) contrast agents (CAs) have gained significant momentum as a promising nanoplatform for detecting tumor tissue in medical diagnosis, due to their favorable capability of enhancing the longitudinal relaxivity (r1) of individual gadolinium ions, delivering to the region of interest a large number of gadolinium ions, and incorporating different functionalities. This mini-review highlights the latest developments and applications, and simultaneously gives some perspectives for their future development.

Graphical abstract: Gadolinium-based nanoscale MRI contrast agents for tumor imaging

Back to tab navigation

Publication details

The article was received on 08 Feb 2017, accepted on 28 Mar 2017 and first published on 28 Mar 2017


Article type: Review Article
DOI: 10.1039/C7TB00382J
Citation: J. Mater. Chem. B, 2017,5, 3431-3461
  •   Request permissions

    Gadolinium-based nanoscale MRI contrast agents for tumor imaging

    Y. Cao, L. Xu, Y. Kuang, D. Xiong and R. Pei, J. Mater. Chem. B, 2017, 5, 3431
    DOI: 10.1039/C7TB00382J

Search articles by author

Spotlight

Advertisements